Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
1 other identifier
interventional
38
2 countries
2
Brief Summary
It's well known that Spinal cord stimulation (SCS) changes the perception of chronic pain in the area stimulated by epidural electrodes. However, we don't know the effect of this type of stimulation on the perception of external sensations (temperature, touch, pressure, and vibration) and sharp pain. Quantitative sensory testing (QST) is used to quantify somatosensory phenotype. This QST battery tests different subtypes of nerve fibres (Aβ, Aδ and C) involved in the transduction of sensory information from the periphery to the spinal cord. The purpose of this study is to evaluate the effects of the SCS on sensory perceptions of patients with chronic pain (CRPS, FBSS). Sensorial perception tests will be carried out in accordance with a standardized procedure (Rolke et al. Pain, 2006). For non-implanted patients, an initial visit will be conducted before the operation. For all participants, two other visits will take place at least 6 months after the operation to perform the tests with and without stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Oct 2015
Typical duration for not_applicable chronic-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 3, 2016
CompletedFirst Posted
Study publicly available on registry
July 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedJuly 17, 2018
July 1, 2018
2.6 years
June 3, 2016
July 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in sensory thresholds
Sensorial perception tests will be carried out in accordance with a standardized procedure (Rolke et al. Pain, 2006). The thermode "Thermal Sensory Analyser TSA-II NeuroSensory Analyzer" and its complement "Vibratory Sensory Analyzer VSA-3000" (Medoc) will be used to assess warm, cold and vibratory detection thresholds, as well as heat and cold painful thresholds. Von Frey monofilaments (Bioseb) will be used to evaluate the mechanical detection threshold. The algometer "Force Ten ™ FDX Digital" (Wagner) will measure the pressure pain threshold. Dynamic mechanical allodynia will be assessed with a standardized brush (SENSELab Brush-05, Somedic). The Neuropen (Owen Mumford) will be used to test the temporal pain summation.
Baseline and at least 6 months post-implantation
Study Arms (2)
Stimulation Off
ACTIVE COMPARATORPatients receiving the intervention "implantation with a spinal cord stimulator". The system is turn Off during the experiment.
Stimulation On
ACTIVE COMPARATORPatients receiving the intervention "implantation with a spinal cord stimulator". The system is turn On during the experiment.
Interventions
Spinal cord stimulator is a reversible and minimally invasive neuromodulation device used for the treatment of various diseases related to chronic pain, including CRPS and FBSS. Briefly, this technology uses electrical pulses to generate action potentials in nerve cells that induce paresthesias (buzzing or tingling sensations) in the affected limb and can relieve pain.
The electrical pulses are induced by one or more electrodes surgically implanted into the epidural space. These electrodes are usually placed under the skin in the abdomen or upper buttock.
Eligibility Criteria
You may qualify if:
- Participant with a diagnosis of CRPS or FBSS that meet International Association for the Study of Pain's criteria;
- Pain in one leg;
- Paresthesia area limited to the treated leg;
- No changes in the programming patterns of the device for a minimum of 30 days before the tests;
- Informed consent.
You may not qualify if:
- \- Wounds or infections at the painful site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Toledo Medical Center
Toledo, Ohio, 43614, United States
CHU de Québec - Université Laval
Québec, G1J 1Z4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michel Prud'Homme, MD, PhD
Chu de Québec - Université Laval
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
June 3, 2016
First Posted
July 20, 2016
Study Start
October 1, 2015
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
July 17, 2018
Record last verified: 2018-07